Could the timing of your period influence how well a surgical wound heals?
NCT ID NCT07724145
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This observational study looks at whether a woman's natural hormone levels, particularly estradiol, influence how well surgical wounds heal after breast reduction surgery. Researchers will measure hormone levels on the day of surgery and check wound healing 21 days later. The goal is to see if healing differs depending on whether surgery occurs before or after ovulation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If a link is found, surgeons might time breast reduction surgery to a specific phase of the menstrual cycle to improve healing.
- What could go wrong
- This is an observational study, not a treatment trial. It can only show an association, not cause and effect. Results may not lead to changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The project population will involve 84 women aged 18 years or older presenting with breast hypertrophy and scheduled for reduction mammoplasty
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptomatic breast hypertrophy * Premenopausal Exclusion Criteria: * Previous breast reduction surgery * Menopausal status * Oral contraceptives * Corticosteroid therapy * History of breast cancer * Active smoking and use of nicotine substitution products
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Estradiol are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital of Geneva
Geneva, 1205, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood tests may reveal hidden healing power of bone marrow stem cells
- Can age slow down dental healing? a study investigates
- Can a seaweed extract help bones regrow in the jaw?
- Can a Blood-Based clot improve mouth healing in people with obesity?
- Seaweed gel may speed healing after dental implants — a trial puts it to the test
- Can an oxygen gel heal medication-damaged jaw bone better than a blood-derived patch?